The global molecular diagnostics industry represents a multi-billion-dollar healthcare market valued between $18 billion and $20 billion, with projections indicating continuous steady expansion driven by oncology and infectious disease testing. North America commands the largest regional revenue share globally due to advanced healthcare infrastructure and high adoption rates.